secwatch.observer — SEC 8-K summary
======================================

Issuer:     Anixa Biosciences Inc (ANIX)
CIK:        0000715446
Form:       8-K
Filed at:   2024-03-22T23:59:59+00:00
Accession:  0001493152-24-010995
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Anixa Biosciences re-elects four directors and ratifies auditor at 2024 annual meeting
--------------------------------------------------------------------------------

- Dr. Amit Kumar, Dr. Arnold Baskies, Emily Gottschalk, and Lewis H. Titterton, Jr. re-elected as directors with 7.9M-7.7M votes for.
- Executive compensation approved on non-binding advisory basis: 6.0M for, 1.8M against, 123K abstain.
- Haskell & White LLP ratified as independent auditor for FY ending Oct 31, 2024: 18.4M for, 80K against, 51K abstain.
- Total shares present at meeting: 18,521,786 out of 31,711,753 eligible shares (58.4% turnout).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/715446/000149315224010995/0001493152-24-010995-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/715446/000149315224010995/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-010995

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer